Literature DB >> 11684174

Abnormal gaze strategies during problem solving in Parkinson's disease.

T L Hodgson1, B Tiesman, A M Owen, C Kennard.   

Abstract

We have taken a novel approach to the study of problem solving involving the detailed analysis of natural scanning eye movements during the 'one touch' Tower of London task. Control subjects and patients with idiopathic Parkinson's disease (PDs) viewed a series of pictures depicting two arrangements of coloured balls in pockets within the upper and lower halves of a computer display. The task was to plan (but not execute) the shortest movement sequence required to rearrange the balls in one half of the display (the Workspace) to match the arrangement in the opposite half (the Goalspace) and indicate the number of moves required for problem solution. As problem complexity increased, control subjects spent proportionally more time fixating the Workspace region. This pattern was found regardless of whether subjects were instructed to solve problems by rearranging balls in the lower or upper visual fields. The distribution of gaze within the Workspace was also found to be problem dependent, with gaze being selectively directed towards the problem critical balls. In contrast, PDs were found to make more errors in the task and failed to show any dissociation in the amount of time fixating the two halves of the display. This pattern suggests that the patients had difficulty in encoding and/or maintaining current goals during problem solving, consistent with a role for fronto-striatal circuits in mechanisms of working memory and attention.

Entities:  

Mesh:

Year:  2002        PMID: 11684174     DOI: 10.1016/s0028-3932(01)00099-9

Source DB:  PubMed          Journal:  Neuropsychologia        ISSN: 0028-3932            Impact factor:   3.139


  13 in total

Review 1.  Gender differences in Parkinson's disease: clinical characteristics and cognition.

Authors:  Ivy N Miller; Alice Cronin-Golomb
Journal:  Mov Disord       Date:  2010-12-15       Impact factor: 10.338

2.  Memory-motor transformations are impaired in Parkinson's disease.

Authors:  Caroline J Ketcham; Timothy L Hodgson; Christopher Kennard; George E Stelmach
Journal:  Exp Brain Res       Date:  2003-01-11       Impact factor: 1.972

3.  Line bisection in Parkinson's disease: investigation of contributions of visual field, retinal vision, and scanning patterns to visuospatial function.

Authors:  Thomas M Laudate; Sandy Neargarder; Alice Cronin-Golomb
Journal:  Behav Neurosci       Date:  2013-01-28       Impact factor: 1.912

4.  Differential patterns of planning impairments in Parkinson's disease and sub-clinical signs of dementia? A latent-class model-based approach.

Authors:  Lena Köstering; Audrey McKinlay; Christoph Stahl; Christoph P Kaller
Journal:  PLoS One       Date:  2012-06-08       Impact factor: 3.240

5.  Biology of Parkinson's disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorder.

Authors:  Garrett E Alexander
Journal:  Dialogues Clin Neurosci       Date:  2004-09       Impact factor: 5.986

6.  Visual symptoms in Parkinson's disease.

Authors:  R A Armstrong
Journal:  Parkinsons Dis       Date:  2011-05-25

7.  Gaze strategies during planning in first-episode psychosis.

Authors:  Vyv C Huddy; Tim L Hodgson; Masuma Kapasi; Stanley H Mutsatsa; Isobel Harrison; Thomas R E Barnes; Eileen M Joyce
Journal:  J Abnorm Psychol       Date:  2007-08

Review 8.  Neuroimaging studies of striatum in cognition part II: Parkinson's disease.

Authors:  Alexandru Hanganu; Jean-Sebastien Provost; Oury Monchi
Journal:  Front Syst Neurosci       Date:  2015-10-08

9.  In your eyes only: deficits in executive functioning after frontal TMS reflect in eye movements.

Authors:  Mathias Lüthi; Katharina Henke; Klemens Gutbrod; Thomas Nyffeler; Silvia Chaves; René M Müri
Journal:  Front Behav Neurosci       Date:  2014-01-27       Impact factor: 3.558

10.  Basal ganglia neuronal activity during scanning eye movements in Parkinson's disease.

Authors:  Tomáš Sieger; Cecilia Bonnet; Tereza Serranová; Jiří Wild; Daniel Novák; Filip Růžička; Dušan Urgošík; Evžen Růžička; Bertrand Gaymard; Robert Jech
Journal:  PLoS One       Date:  2013-11-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.